Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hennenberg

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|June 29, 2007
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseJonel Trebicka, Martin Hennenberg, Wim Laleman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2010
Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosisChristian J Steib, Anna C Hartmann, Christoph v Hesler, et al.
BJU International|March 5, 2011
α1-adrenoceptor activation induces phosphorylation of β2-adrenoceptors in human prostate tissueMartin Hennenberg, Frank Strittmatter, Sebastian Walther, et al.
Molecular Pharmacology|August 5, 2021
ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal CellsRuixiao Wang, Stephanie Schneider, Oliver T Keppler, et al.
Gut|June 17, 2010
Amiloride reduces portal hypertension in rat liver cirrhosisChristian J Steib, Martin Hennenberg, Frigga Beitinger, et al.
World Journal of Urology|December 11, 2025
TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progressionYajie Xu, Sheng Hu, Laurenz Berger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 2023
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscleSheng Hu, Moritz Trieb, Ru Huang, et al.
The Journal of Urology|April 3, 2013
Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivityClaudius Füllhase, Martin Hennenberg, Armin Giese, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 24, 2019
The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusorBingsheng Li, Xiaolong Wang, Beata Rutz, et al.
Life Sciences|September 22, 2020
Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cellsRuixiao Wang, Qingfeng Yu, Xiaolong Wang, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|June 29, 2007
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthaseJonel Trebicka, Martin Hennenberg, Wim Laleman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2010
Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosisChristian J Steib, Anna C Hartmann, Christoph v Hesler, et al.
BJU International|March 5, 2011
α1-adrenoceptor activation induces phosphorylation of β2-adrenoceptors in human prostate tissueMartin Hennenberg, Frank Strittmatter, Sebastian Walther, et al.
Molecular Pharmacology|August 5, 2021
ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal CellsRuixiao Wang, Stephanie Schneider, Oliver T Keppler, et al.
Gut|June 17, 2010
Amiloride reduces portal hypertension in rat liver cirrhosisChristian J Steib, Martin Hennenberg, Frigga Beitinger, et al.
World Journal of Urology|December 11, 2025
TERT expression in human prostate tissue reveals a potential molecular switch in benign prostatic hyperplasia progressionYajie Xu, Sheng Hu, Laurenz Berger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 2023
Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscleSheng Hu, Moritz Trieb, Ru Huang, et al.
The Journal of Urology|April 3, 2013
Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivityClaudius Füllhase, Martin Hennenberg, Armin Giese, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 24, 2019
The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusorBingsheng Li, Xiaolong Wang, Beata Rutz, et al.
Life Sciences|September 22, 2020
Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cellsRuixiao Wang, Qingfeng Yu, Xiaolong Wang, et al.
Pageof 11